WO2000002863A1 - Verfahren zur herstellung von carbonyldiimidazolen - Google Patents

Verfahren zur herstellung von carbonyldiimidazolen Download PDF

Info

Publication number
WO2000002863A1
WO2000002863A1 PCT/EP1999/004729 EP9904729W WO0002863A1 WO 2000002863 A1 WO2000002863 A1 WO 2000002863A1 EP 9904729 W EP9904729 W EP 9904729W WO 0002863 A1 WO0002863 A1 WO 0002863A1
Authority
WO
WIPO (PCT)
Prior art keywords
imidazole
base
nitrogen base
nitrogen
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1999/004729
Other languages
German (de)
English (en)
French (fr)
Inventor
Armin Stamm
Jochem Henkelmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Priority to US09/720,913 priority Critical patent/US6353115B1/en
Priority to HU0102739A priority patent/HUP0102739A3/hu
Priority to CA002336657A priority patent/CA2336657C/en
Priority to AU54098/99A priority patent/AU5409899A/en
Priority to KR1020017000204A priority patent/KR20010071762A/ko
Priority to JP2000559094A priority patent/JP2002520318A/ja
Priority to DE59907811T priority patent/DE59907811D1/de
Priority to EP99939989A priority patent/EP1095024B1/de
Publication of WO2000002863A1 publication Critical patent/WO2000002863A1/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Definitions

  • the present invention relates to an improved process for the preparation of carbonyldumidazoles from imidazoles and phosgene while avoiding the coupled product irnidazole hydrochloride.
  • Carbonyldiimidazole is a frequently used reagent for the introduction of carbonyl groups, for example for the production of carbonates, ureas or urethanes or for the activation of unreactive reactants in ester or amide synthesis (Angew. Chem. 74 (1962), 407).
  • CDI The more elegant way to make CDI is that originally developed by Staab et al. direct phosgenation of imidazole (Liebigs Ann. Chem. 609 (1957), 75; Chem. Ber. 96 (1963), 3374; Org. Synth. Coll. Vol V (1973), 201). Although two moles of In idazole hydrochloride per mole of CDI are formed as a by-product, the first can be converted back to imidazole by basic work-up and returned to the phosgenation:
  • EP-A-0 692 476 describes that described in the previous references Synthesis route only extended by a method for dewatering the solvent. However, the original regulations remain very difficult. The imidazole hydrochloride formed as a by-product must be separated from the CDI-containing reaction solution at high temperatures (80 to 100 ° C.) by filtration with exclusion of moisture. To maintain a sufficiently high product quality, a high level of technical effort must be made since the CDI is extremely sensitive to hydrolysis.
  • a disadvantage of all previous processes for the direct phosgenation of imidazole is the formation of the coproduct imidazole hydrochloride, which has to be recycled in an additional process step and by which the space-time yield is halved.
  • the older, unpublished WO 98/31672 relates to a process for the production of e.g. CDI by implementing e.g. Imidazole with phosgene in the presence of an organic base, e.g. Tri (n-butyl) amine.
  • an organic base e.g. Tri (n-butyl) amine.
  • the object of the present invention is to provide a process for the preparation of carbonyldumidazoles from imidazoles and phosgene which avoids the disadvantages mentioned.
  • R is hydrogen or a C 4 alkyl radical and R is hydrogen or
  • Methyl radical is by reacting at least one imidazole of the general formulas Ha and ü
  • the formation of imidazole hydrochloride is avoided by adding an organic base, so that the imidazole used can be completely converted to the carbonyldiimidazole.
  • the hydrochloric acid which is inevitably obtained as a by-product is bound by a stronger base than imidazole, so that the entire imidazole used can react to form carbonyldiimidazole.
  • the hydrochloride of the auxiliary base then only has to be separated from the product and, after being converted into the free base, returned to the synthesis.
  • Imidazole is itself a weak base (pKb value about 7) and serves as both reagent and acid scavenger in the phosgenation reaction.
  • a stronger nitrogen base for example a tertiary aliphatic amine, in particular tributylamine, during the synthesis either the stronger base is preferably protonated or imidazole is re-formed from the hydrochloride formed:
  • the imidazole which is thereby again present as a free base can be further phosgenated.
  • an equivalent amount of tertiary nitrogen base is required according to the following gross equation.
  • the advantage of the process is, inter alia, that the space-time yield is twice as high as that of the processes described hitherto, since the imidazole used is completely converted and not half of the imidazole has to be recycled as hydrochloride unused.
  • the reaction is carried out in an inert solvent, preferably at a temperature in the range from 60 to 100 ° C., particularly preferably at 60 to 80 ° C. in a substituted aromatic hydrocarbon.
  • Xylene or chlorobenzene is preferably used, where xylene can be present as a mixture of o-, m- and p-xylene or as one of the isomers. Xylene or its isomer mixtures are particularly preferably used.
  • any base with a pKb value lower than the pKb value of imidazole is suitable as the tertiary nitrogen base.
  • a tertiary amine of the general formula NR 3 is preferably used as the nitrogen base, where R in each case independently of one another is branched or unbranched Ci-io-alkyl radicals or two of the radicals with a nitrogen atom form a 5- or 6-membered heterocycloaliphatic or heteroaromatic ring which additionally can be interrupted by one or two oxygen or nitrogen atoms.
  • the nitrogen base is preferably a tertiary aliphatic amine in which the radicals R are identical and are C -alkyl radicals, such as trimethyl, triethyl, tripropyl,
  • Tri-n-butylarnine examples of amines in which two of the residues form a ring are N-alkylpyrrolidines and N-alkylpiperidines. Examples of rings interrupted by heteroatoms are given in N-alkylmorpholines and NjNOialkylpiperazinen.
  • the amine hydrochloride formed should precipitate out of the reaction mixture as a solid phase.
  • the reaction solution remains homogeneous at higher temperatures (50 to 60 ° C). Only when it cools does carbonyldiimidazole precipitate out of the reaction mixture in colorless needles, while the tributylamine hydrochloride remains completely in the solvent.
  • the CDI is apparently pushed out of solution by the amine hydrochloride due to a salting-out effect, while the tributylamine hydrochloride remains dissolved in the solvent due to its longer and polar alkyl radicals.
  • the CDI formed can be crystallized out by cooling the reaction mixture and separated off as a solid, the hydrochloride formed being the
  • the failed CDI can be removed simply by suction under inert gas or by separation using a
  • Solvent-dissolved hydrochloride of the tertiary amine can be neutralized with a stronger aqueous inorganic base, preferably an aqueous one
  • Solvent can then be separated from the aqueous phase and returned to the
  • a total of 51 g (0.5 mol) of phosgene are gasified at 72 to 83 ° C. within 30 minutes. After phosgene has been added, stirring is continued at 65 ° C. for 60 minutes. Working up is carried out as in Example 1. After drying, 57 g of CDI with a melting point of 112 ° C. are obtained.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
PCT/EP1999/004729 1998-07-08 1999-07-06 Verfahren zur herstellung von carbonyldiimidazolen Ceased WO2000002863A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US09/720,913 US6353115B1 (en) 1998-07-08 1999-07-06 Method for producing carbonyl diimidazoles
HU0102739A HUP0102739A3 (en) 1998-07-08 1999-07-06 Method for producing carbonyl diimidazoles
CA002336657A CA2336657C (en) 1998-07-08 1999-07-06 Method for producing carbonyl diimidazoles
AU54098/99A AU5409899A (en) 1998-07-08 1999-07-06 Method for producing carbonyl diimidazoles
KR1020017000204A KR20010071762A (ko) 1998-07-08 1999-07-06 카르보닐디이미다졸의 제조 방법
JP2000559094A JP2002520318A (ja) 1998-07-08 1999-07-06 カルボニルジイミダゾールの製造方法
DE59907811T DE59907811D1 (de) 1998-07-08 1999-07-06 Verfahren zur herstellung von carbonyldiimidazolen
EP99939989A EP1095024B1 (de) 1998-07-08 1999-07-06 Verfahren zur herstellung von carbonyldiimidazolen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830556.7 1998-07-08
DE19830556A DE19830556A1 (de) 1998-07-08 1998-07-08 Verfahren zur Herstellung von Carbonyldiimidazolen

Publications (1)

Publication Number Publication Date
WO2000002863A1 true WO2000002863A1 (de) 2000-01-20

Family

ID=7873373

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/004729 Ceased WO2000002863A1 (de) 1998-07-08 1999-07-06 Verfahren zur herstellung von carbonyldiimidazolen

Country Status (10)

Country Link
US (1) US6353115B1 (https=)
EP (1) EP1095024B1 (https=)
JP (1) JP2002520318A (https=)
KR (1) KR20010071762A (https=)
CN (1) CN1214012C (https=)
AU (1) AU5409899A (https=)
CA (1) CA2336657C (https=)
DE (2) DE19830556A1 (https=)
HU (1) HUP0102739A3 (https=)
WO (1) WO2000002863A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095355A1 (ja) * 2004-03-30 2005-10-13 Hodogaya Chemical Co., Ltd. N,n’-カルボニルジイミダゾールの製造方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10359797A1 (de) * 2003-12-19 2005-07-21 Bayer Chemicals Ag Verfahren zur Herstellung von N,N'-Carbonyldiazolen
CN102321026A (zh) * 2011-08-02 2012-01-18 海门瑞一医药科技有限公司 羰基二咪唑的生产工艺
KR102473775B1 (ko) * 2022-04-15 2022-12-05 ㈜파인켐 카르밤산염 유도체 화합물 제조방법
CN120398768B (zh) * 2025-04-30 2025-10-17 江西金凯化工有限公司 一种利用固体三光气的n,n'-羰基二咪唑高纯度制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991071A (en) * 1973-06-21 1976-11-09 The Boots Company Limited Fungicidal compositions containing substituted imidazoles
EP0692476A2 (de) * 1994-07-11 1996-01-17 Bayer Ag Verbessertes Verfahren zur Herstellung von N,N'-Carbonyldiazolen, insbesondere N,N'-Carbonyldiimidazol
US5552554A (en) * 1992-11-13 1996-09-03 E. I. Du Pont De Nemours And Company Imidazole and triazole carboxylates, and processes for preparing 2,4-oxazolidinediones
WO1998031672A1 (en) * 1997-01-17 1998-07-23 Ppg Industries Ohio, Inc. Method of producing n,n'-diazole compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118585B1 (https=) * 1963-11-04 1966-10-26
GB1408877A (en) * 1971-12-07 1975-10-08 Boots Co Ltd Substituted imidazoles and their use as pesticides
JPS5816639A (ja) * 1981-04-23 1983-01-31 ザ・プロクタ−・エンド・ギヤンブル・カンパニ− 塩、レシチン及び親水性シリカを含有する脂肪組成物
DE3134933A1 (de) * 1981-09-03 1983-03-31 Hoechst Ag, 6230 Frankfurt "harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente sowie deren verwendung"
JPS58152863A (ja) * 1982-03-04 1983-09-10 Sumitomo Chem Co Ltd カルボニルジイミノビスベンゼンスルホニルクロリド類の製造方法
US4957933A (en) * 1989-04-21 1990-09-18 E. I. Du Pont De Nemours And Company Fungicidal oxazolidinones
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
JP3021705B2 (ja) * 1991-03-01 2000-03-15 住友化学工業株式会社 対称型1,3−ジ置換尿素の製造法
JPH08253456A (ja) * 1995-03-17 1996-10-01 Mitsubishi Chem Corp 2−ペルヒドロピリミジノン誘導体及びそれを有効成分とする除草剤、並びにその製造中間体
DE19833913A1 (de) * 1998-07-28 2000-02-03 Bayer Ag Verfahren zur Herstellung von N,N'-Carbonyldiazolen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991071A (en) * 1973-06-21 1976-11-09 The Boots Company Limited Fungicidal compositions containing substituted imidazoles
US5552554A (en) * 1992-11-13 1996-09-03 E. I. Du Pont De Nemours And Company Imidazole and triazole carboxylates, and processes for preparing 2,4-oxazolidinediones
EP0692476A2 (de) * 1994-07-11 1996-01-17 Bayer Ag Verbessertes Verfahren zur Herstellung von N,N'-Carbonyldiazolen, insbesondere N,N'-Carbonyldiimidazol
WO1998031672A1 (en) * 1997-01-17 1998-07-23 Ppg Industries Ohio, Inc. Method of producing n,n'-diazole compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WALTER W ET AL: "ZUR UMSETZUNG VON AZOLEN MIT ANORGANISCHEN SAEURECHLORIDEN", LIEBIGS ANNALEN DER CHEMIE, no. 11, 1 January 1979 (1979-01-01), pages 1756 - 1767, XP002064142, ISSN: 0170-2041 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095355A1 (ja) * 2004-03-30 2005-10-13 Hodogaya Chemical Co., Ltd. N,n’-カルボニルジイミダゾールの製造方法
EP1731510A4 (en) * 2004-03-30 2010-08-04 Hodogaya Chemical Co Ltd PROCESS FOR PREPARING N, N'-CARBONYLDIIMIDAZOLE
US7964626B2 (en) 2004-03-30 2011-06-21 Hodogaya Chemical Co., Ltd. Process for producing N,N′-carbonyldiimidazole

Also Published As

Publication number Publication date
DE59907811D1 (de) 2003-12-24
EP1095024A1 (de) 2001-05-02
AU5409899A (en) 2000-02-01
EP1095024B1 (de) 2003-11-19
CN1308613A (zh) 2001-08-15
CA2336657C (en) 2009-02-24
US6353115B1 (en) 2002-03-05
HUP0102739A2 (hu) 2001-11-28
HUP0102739A3 (en) 2003-03-28
CN1214012C (zh) 2005-08-10
KR20010071762A (ko) 2001-07-31
JP2002520318A (ja) 2002-07-09
DE19830556A1 (de) 2000-01-13
CA2336657A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
EP0708109A1 (de) Verfahren zur Herstellung phosphorhaltiger Dicarbonsäuren
EP1345939B1 (de) Verfahren zur herstellung von sulfonamid-substituierten imidazotriazinonen
DE102009060150B4 (de) Verfahren zur Herstellung von Säureadditionssalzen von Pyrazolen
EP1095024B1 (de) Verfahren zur herstellung von carbonyldiimidazolen
WO1998058914A1 (de) Verfahren zur herstellung substituierter pyrazole
DE2934746A1 (de) Oxoimidazolinalkansaeuren, deren salze und ester sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel
EP0988290B1 (de) Carbonyldiimidazole, daraus abgeleitete ester und verfahren zu ihrer herstellung
DD228550A1 (de) Verfahren zur kontinuierlichen herstellung von methylsiliconharzen
EP0018473A1 (de) Verfahren zur Herstellung von beta-Alkoxy-acrylnitrilen, 3-Amino-acrylnitrilen und 2-Cyano-vinylestern
EP1024140B1 (de) Verfahren zur N-Alkylierung von cyclischen Cyanamidinen
DE1543328B2 (de) Verfahren zur herstellung von aminimiden
DE2538095A1 (de) Neue organische verbindungen, ihre herstellung und verwendung
DE10311763A1 (de) Verfahren zur Herstellung von 2-Cyan-3-hydroxy-N-(phenyl)but-2-enamiden
EP1007510B1 (de) Verfahren zur herstellung von thiochlorformiaten
DE3140632A1 (de) Verfahren zur herstellung von (alpha)-dicyano-trimethylsilyloxy-verbindungen (i)
DE4219972A1 (de) Arzneimittel mit antineoplastischer wirkung enthaltend als wirkstoff octadecyl-(2-(n-methylpiperidino)-ethyl)-phosphat und verfahren zu dessen herstellung
DE3231052A1 (de) Verfahren zur herstellung von reinem diacetonitril
DE2839084C2 (de) Verfahren zur Herstellung von Tri-(allylisocyanurat)
EP0122479A1 (de) 3-Chlor-1,1-dialkoxyacetone und Verfahren zu ihrer Herstellung
AT236393B (de) Verfahren zur Herstellung von neuen 5H-Dibenz[b,f] azepinen
DE1620014C3 (de) Verfahren zur Herstellung von (2-Methyl-3-indolyl)-essigsäure-tertbutylestern
DE2917014A1 (de) Aethylenglykoldiester und verfahren zu deren herstellung
DD296072A5 (de) Verfahren zur herstellung von neuen 1,1'-disubstituierten alpha, alpha'-bis-[pyrazolyloxy-(3)]essigsaeuren und deren salzen
EP0311033A2 (de) 3-Phthalimidothiophene bzw. deren Additionsprodukte mit Morpholin, Verfahren zu deren Herstellung, deren Verwendung zur Herstellung von 3-Aminothiophenen und das 3-Amino-5-chlorthiophen
DE1932417A1 (de) Verfahren zur Herstellung von Di-neocarbonsaeuren

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99808386.0

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA CN HU JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1999939989

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09720913

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2000 559094

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2336657

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020017000204

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1999939989

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020017000204

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1999939989

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1020017000204

Country of ref document: KR

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)